These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 21498081)
1. Radiosynthesis of a new PSMA targeting ligand ([18F]FPy-DUPA-Pep). Malik N; Machulla HJ; Solbach C; Winter G; Reske SN; Zlatopolskiy B Appl Radiat Isot; 2011 Jul; 69(7):1014-8. PubMed ID: 21498081 [TBL] [Abstract][Full Text] [Related]
2. 2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer. Chen Y; Pullambhatla M; Foss CA; Byun Y; Nimmagadda S; Senthamizhchelvan S; Sgouros G; Mease RC; Pomper MG Clin Cancer Res; 2011 Dec; 17(24):7645-53. PubMed ID: 22042970 [TBL] [Abstract][Full Text] [Related]
3. Preclinical Evaluation of Cardinale J; Schäfer M; Benešová M; Bauder-Wüst U; Leotta K; Eder M; Neels OC; Haberkorn U; Giesel FL; Kopka K J Nucl Med; 2017 Mar; 58(3):425-431. PubMed ID: 27789722 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and pre-clinical evaluation of a new class of high-affinity Kelly J; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Ponnala S; Babich JW Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):647-661. PubMed ID: 27847991 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer. Harada N; Kimura H; Onoe S; Watanabe H; Matsuoka D; Arimitsu K; Ono M; Saji H J Nucl Med; 2016 Dec; 57(12):1978-1984. PubMed ID: 27417647 [TBL] [Abstract][Full Text] [Related]
6. Tumor Uptake of Triazine Dendrimers Decorated with Four, Sixteen, and Sixty-Four PSMA-Targeted Ligands: Passive versus Active Tumor Targeting. Lim J; Guan B; Nham K; Hao G; Sun X; Simanek EE Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31466360 [TBL] [Abstract][Full Text] [Related]
7. Prostate-Specific Membrane Antigen Targeted Therapy of Prostate Cancer Using a DUPA-Paclitaxel Conjugate. Lv Q; Yang J; Zhang R; Yang Z; Yang Z; Wang Y; Xu Y; He Z Mol Pharm; 2018 May; 15(5):1842-1852. PubMed ID: 29608845 [TBL] [Abstract][Full Text] [Related]
8. Enzymatic radiosynthesis of a Lowe PT; Dall'Angelo S; Fleming IN; Piras M; Zanda M; O'Hagan D Org Biomol Chem; 2019 Feb; 17(6):1480-1486. PubMed ID: 30681115 [TBL] [Abstract][Full Text] [Related]
9. Automated Synthesis of Fluorine-18 Labeled CXCR4 Ligand via the Conjugation with Nicotinic Acid Basuli F; Zhang X; Phelps TE; Jagoda EM; Choyke PL; Swenson RE Molecules; 2020 Aug; 25(17):. PubMed ID: 32867358 [TBL] [Abstract][Full Text] [Related]
10. Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer. Foss CA; Mease RC; Fan H; Wang Y; Ravert HT; Dannals RF; Olszewski RT; Heston WD; Kozikowski AP; Pomper MG Clin Cancer Res; 2005 Jun; 11(11):4022-8. PubMed ID: 15930336 [TBL] [Abstract][Full Text] [Related]
12. The efficiency of Wang M; McNitt CD; Wang H; Ma X; Scarry SM; Wu Z; Popik VV; Li Z Chem Commun (Camb); 2018 Jul; 54(56):7810-7813. PubMed ID: 29946609 [TBL] [Abstract][Full Text] [Related]
14. Radiofluorination of PSMA-HBED via Al(18)F(2+) Chelation and Biological Evaluations In Vitro. Malik N; Baur B; Winter G; Reske SN; Beer AJ; Solbach C Mol Imaging Biol; 2015 Dec; 17(6):777-85. PubMed ID: 25869080 [TBL] [Abstract][Full Text] [Related]
15. One step radiosynthesis of 6-[(18)F]fluoronicotinic acid 2,3,5,6-tetrafluorophenyl ester ([(18)F]F-Py-TFP): a new prosthetic group for efficient labeling of biomolecules with fluorine-18. Olberg DE; Arukwe JM; Grace D; Hjelstuen OK; Solbakken M; Kindberg GM; Cuthbertson A J Med Chem; 2010 Feb; 53(4):1732-40. PubMed ID: 20088512 [TBL] [Abstract][Full Text] [Related]
16. Bispecific radioligands targeting prostate-specific membrane antigen and gastrin-releasing peptide receptors on the surface of prostate cancer cells. Liolios C; Sachpekidis C; Schäfer M; Kopka K J Labelled Comp Radiopharm; 2019 Jun; 62(8):510-522. PubMed ID: 31070273 [TBL] [Abstract][Full Text] [Related]
17. PSMA-targeted polyinosine/polycytosine vector induces prostate tumor regression and invokes an antitumor immune response in mice. Langut Y; Talhami A; Mamidi S; Shir A; Zigler M; Joubran S; Sagalov A; Flashner-Abramson E; Edinger N; Klein S; Levitzki A Proc Natl Acad Sci U S A; 2017 Dec; 114(52):13655-13660. PubMed ID: 29229829 [TBL] [Abstract][Full Text] [Related]
18. Validation of a [Al Al-Momani E; Israel I; Samnick S Appl Radiat Isot; 2017 Dec; 130():102-108. PubMed ID: 28950199 [TBL] [Abstract][Full Text] [Related]
19. Fast indirect fluorine-18 labeling of protein/peptide using the useful 6-fluoronicotinic acid-2,3,5,6-tetrafluorophenyl prosthetic group: A method comparable to direct fluorination. Basuli F; Zhang X; Woodroofe CC; Jagoda EM; Choyke PL; Swenson RE J Labelled Comp Radiopharm; 2017 Mar; 60(3):168-175. PubMed ID: 27990672 [TBL] [Abstract][Full Text] [Related]
20. Novel Bispecific PSMA/GRPr Targeting Radioligands with Optimized Pharmacokinetics for Improved PET Imaging of Prostate Cancer. Liolios C; Schäfer M; Haberkorn U; Eder M; Kopka K Bioconjug Chem; 2016 Mar; 27(3):737-51. PubMed ID: 26726823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]